Table 1. Antiferroptotic Effects of MB/MV Analogues (1–5) in FRDA Lymphocytes against RSL3-Induced Lipid Peroxidationa.
Compound | RSL3 challenge lipid peroxidation inhibition EC50 (nM) |
---|---|
MB | 88 ± 13 |
Acetylated MBb | >2500 |
MV | 26 ± 3 |
1a | 76 ± 6 |
1b | 14 ± 1 |
2a | 53 ± 3 |
2b | 12 ± 1 |
3a | 38 ± 3 |
3b | 9 ± 1 |
4a | 54 ± 5 |
4b | 16 ± 1 |
5a | 70 ± 5 |
5b | 25 ± 3 |
Lip-1 | 22 ± 2 |
Fer-1 | 48 ± 2 |
α-TOH | >500 |